LEARN ALL ABOUT NEW OPNEO AUTHORISATION DEADLINES

WHEN?

📅 Thursday 17th December 2020
🕚 11:00 am - 11:45 am (CEST - Europe/Paris)

-------------------------

OPnEO AUTHORISATION DEADLINES & CoVID-19

OPnEO is an endocrine disruptor which has made its entry in Annex XIV of REACH already in 2017, with a latest application date on 4th July 2019 and a sunset date on 4th January 2021.

Whereas most applications for authorisations for OPnEO have therefore already been submitted to the European Chemicals Agency, a new use of OPnEO related to the Covid-19 pandemic has emerged since December 2019.

Find out about the latest European Commission Decision, in the last adoption stage, postponing the latest application date and the sunset date for OPnEO used for medicinal products, medical devices, or accessories to medical devices, including IVD, for the diagnosis, treatment or prevention of COVID-19.

AGENDA

OPnEO main properties of interest for medicinal products, devices or accessories to medical devices
New latest application date and sunset date for COVID-19 use of OPnEO
Conditions to benefit from those new deadline

Duration : 30min of presentation + 10min of Q/A

REGISTER NOW!

Benoît SOTTON
REACH Authorisation Project Manager
& Toxicologist Expert

Former researcher specialising in environmental projects (ecology and ecotoxicology), Benoît brings his knowledge as an expert on CSR exposure scenarios, risk assessment and REACH regulation.

Souleymane GAYE
REACH Authorisation
& Public affairs consultant

Souleymane has extensive experience as a strategic analysis consultant in the field of business intelligence. He brings his expertise in socio-economic analysis and focuses on regulatory issues related to REACH and authorisation.